Nuclear Medicine News and Research

RSS

Nuclear medicine is a branch or specialty of medicine and medical imaging that uses radioactive isotopes (radionuclides) and relies on the process of radioactive decay in the diagnosis and treatment of disease. In nuclear medicine procedures, radionuclides are combined with other chemical compounds or pharmaceuticals to form radiopharmaceuticals.

Daytime eating maintains circadian alignment, prevents glucose intolerance despite mistimed sleep

What are the effects of eating during the nighttime instead of the daytime? New research, focused on a simulation of night shift work, may hold implications for people eating at atypical times -; like those experiencing jet lag, circadian rhythm sleep disorders, or who tend to sleep late during the weekends.

6 Dec 2021

Brain immune cells take up large amounts of sugar at the beginning of neurodegenerative disease

At the beginning of neurodegenerative disease, the immune cells of the brain – the "microglia" – take up glucose, a sugar molecule, to a much greater extent than hitherto assumed.

18 Oct 2021

New radioimmunotherapy effectively reverses resistance to lymphoma therapy

A new radioimmunotherapy has proven effective in reversing resistance to the most commonly used lymphoma drug, rituximab, according to research published in the October issue of The Journal of Nuclear Medicine.

9 Oct 2020

New radiopharmaceutical offers precise diagnosis and treatment of prostate cancer in preclinical studies

Researchers have developed a new pair of agents that show exceptional effectiveness for precision diagnosis and treatment of prostate cancer in preclinical studies.

14 Jul 2020

PET radiotracer is safe and effective for imaging malignant brain tumors

A first-in-human study presented at the Society of Nuclear Medicine and Molecular Imaging 2020 Annual Meeting has demonstrated the safety, favorable pharmacokinetic and dosimetry profile of 64Cu-EBRGD, a new, relatively long-lived PET tracer, in patients with glioblastomas.

14 Jul 2020

PET reveals the existence of inter-organ communication between the heart and kidneys after heart attack

Whole body positron emission tomography (PET) has, for the first time, illustrated the existence of inter-organ communication between the heart and kidneys via the immune system following acute myocardial infarction, or heart attack.

14 Jul 2020

Peter S. Conti awarded 2020 Benedict Cassen Prize for pioneering work in cancer imaging

Peter S. Conti, MD, PhD, known for his pioneering work in the diagnosis and management of cancer, was awarded the Benedict Cassen Prize during the 2020 Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging.

14 Jul 2020

New radiotracer provides a quantitative measure of disease progression after stroke

A new radiotracer, 18F-SynVesT-2, can directly assess synaptic density changes in the brain, providing an objective and quantitative measure of disease progression after stroke.

14 Jul 2020

Functional bone imaging technique reveals the progression of knee osteoarthritis

A new approach to functional bone imaging has established that bone metabolism is abnormally elevated in patients with knee osteoarthritis.

14 Jul 2020

uEXPLORER TB-PET/CT scanner captures complete picture of systemic inflammatory arthritis

For the first time, physicians can examine the systemic burden of inflammatory arthritis simultaneously across all joints and organ systems, using the high-sensitivity, high-resolution uEXPLORER total-body positron emission tomography/computed tomography (TB-PET/CT) scanner.

14 Jul 2020

Total-body dynamic PET scans can produce high-quality images of metastatic cancer

Results from the first study using uEXPLORER to conduct total-body dynamic positron emission tomography (PET) scans in cancer patients show that it can be used to generate high-quality images of metastatic cancer.

14 Jul 2020

New molecular imaging method can identify the location of pain generators

A new molecular imaging approach utilizing 18F-FDG positron emission tomography (PET) and magnetic resonance imaging (MRI) can precisely identify the location of pain generators in chronic pain sufferers, often precipitating a new management plan for patients.

14 Jul 2020

Targeted radionuclide therapy creates a favorable tumor microenvironment in prostate cancer

Targeted radionuclide therapy has been found to create a favorable tumor microenvironment in prostate cancer that improves the effectiveness of immunotherapies.

14 Jul 2020

Study confirms the efficacy of PSMA PET/CT in detection and management of recurrent prostate cancer

New research confirms the high impact of PSMA PET/CT in the detection and management of recurrent disease in prostate cancer patients.

14 Jul 2020

Nuclear Medicine News and Research

Daytime eating maintains circadian alignment, prevents glucose intolerance despite mistimed sleep

Brain immune cells take up large amounts of sugar at the beginning of neurodegenerative disease

New radioimmunotherapy effectively reverses resistance to lymphoma therapy

New radiopharmaceutical offers precise diagnosis and treatment of prostate cancer in preclinical studies

PET radiotracer is safe and effective for imaging malignant brain tumors

PET reveals the existence of inter-organ communication between the heart and kidneys after heart attack

Peter S. Conti awarded 2020 Benedict Cassen Prize for pioneering work in cancer imaging

New radiotracer provides a quantitative measure of disease progression after stroke

Functional bone imaging technique reveals the progression of knee osteoarthritis

uEXPLORER TB-PET/CT scanner captures complete picture of systemic inflammatory arthritis

Total-body dynamic PET scans can produce high-quality images of metastatic cancer

New molecular imaging method can identify the location of pain generators

Targeted radionuclide therapy creates a favorable tumor microenvironment in prostate cancer

Study confirms the efficacy of PSMA PET/CT in detection and management of recurrent prostate cancer

Turning to Sustainable Science for a Healthier Tomorrow

Challenges in Drug Discovery; Where are we now, and where are we going?

How Important is the European Ecosystem to Life Sciences Research?

Latest Life Science News